< 回列表
Charles A. Leath
- Director, Division of Gynecologic Oncology Department of Obstetrics & Gynecology The University of Alabama at Birmingham Women’s & Infants Center
- Sanford Hospital Staff, University of South Dakota Medical Center Sioux Falls, South Dakota
- University of Alabama Hospital Staff, Birmingham, Alabama
- North Mississippi Medical Center Staff,Tupelo, Mississippi
The evolving treatment paradigm of advanced endometrial cancer
| 角色 | 講師 |
| 日期時間 | 05/02 14:30 - 15:10 |
| 地點 | 701E |
Integrating of immunotherapy into treatment of cervical cancer: how far have we come?
| 角色 | 講師 |
| 日期時間 | 05/02 15:10 - 15:50 |
| 地點 | 701E |
學歷 / 訓練
1994, Bachelor of Science in Biological Sciences, Magna Cum Laude, Honors Program, The Citadel, The Military College of South Carolina
1993, Non-degree Seeking Student, University of South Carolina
1998, M.D., Medical University of South Carolina
2014, Masters of Science in Public Health, Clinical and Translation Sciences, University of Alabama at Birmingham School of Public Health
專業與研究經歷
1998 - 2001, Intern, Resident, Obstetrics and Gynecology,University of Alabama at Birmingham, Birmingham, Alabama
2001 - 2002, Administrative Chief Resident, Obstetrics and Gynecology,University of Alabama at Birmingham, Birmingham, Alabama
2002 - 2003, Research Fellow, Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, Alabama
2003 - 2005, Clinical Fellow/Instructor, Gynecologic Oncology, Department of Obstetrics & Gynecology, University of Alabama at Birmingham
2005 - 2011, Assistant Professor of Obstetrics & Gynecology, F. Edward Hébert School of Medicine Uniformed Services University of the Health Sciences, Bethesda, Maryland
2011 - 2012, Associate Professor of Obstetrics & Gynecology, F. Edward Hébert School of Medicine Uniformed Services University of the Health Sciences, Bethesda, Maryland
2012 - 2016, Associate Professor of Obstetrics & Gynecology, Department of Obstetrics & Gynecology, University of Alabama at Birmingham
2016 - 2017, Associate Professor of Obstetrics & Gynecology (Tenured), Department of Obstetrics & Gynecology, University of Alabama at Birmingham
2017 - Present, Professor of Obstetrics & Gynecology (Tenured), Department of Obstetrics & Gynecology, University of Alabama at Birmingham
2018 - Present, Ellen Gregg Shook Culverhouse Endowed Chair, Department of Obstetrics & Gynecology, University of Alabama at Birmingham
2021 - Present, Division Director, Division of Gynecologic Oncology Department of Obstetrics & Gynecology, University of Alabama at Birmingham
獲獎與榮譽
1998-2005 Department of OB/GYN Excellence in Medical Student Education,Medical University of South Carolina
2001-2002 Department of OB/GYN Chairman’s Award of Excellence,University of Alabama at Birmingham (Residency and Fellowship)
2002-2003 NCI T32 (1 T32 CA 91078-1 A1) Fellowship Grant for Research Training in Surgical Oncology,University of Alabama at Birmingham (Residency and Fellowship)
2007-2011 Air Force Outstanding Unit Award,Brooke Army Medical Center
2007
American Medical Association Physician's Recognition Award with Commendation,Brooke Army Medical Center
2007
Air Force Excellence in Clinical/Academic Teaching (MF SEI),Brooke Army Medical Center
2011
Meritorious Service Medal,Brooke Army Medical Center
2012-2015 Institutional K12 (K12 HD 1258) Women's Reproductive Health Research (WRHR) Senior Scholar,University of Alabama at Birmingham
2013
American College of Obstetricians and Gynecologists District X Mentor of the Year Award,University of Alabama at Birmingham
2019-2024 UAB Office of Patient Experience – Excellence in Patient Communication,University of Alabama at Birmingham
2012-2024,Department of OB/GYN Excellence in Resident Education / Department of OB/GYN Excellence in Medical Student Education,University of Alabama at Birmingham
2020
Alpha Omega Alph,University of Alabama at Birmingham
2022-2023,2024-2025 APGO Excellence in Teaching Award,University of Alabama at Birmingham
重要出版品
- Coleman RL, Fleming GF, Brady MF, Swisher EM, Steffensen KD, Friedlander M, Okamoto A, Moore KN, Leath CA, Cella D, Sun Z, Patel S, Tang Z, Ratajczak CK, Aghajanian C, Bookman MA. Veliparib concomitant with first-line chemotherapy and as maintenance therapy in ovarian cancer: Final overall survival and disease-related symptoms results. Eur J Cancer 225:115587, 2025
- Ragland K, Pogue J, Simiele E, Simiele S, Soike M, Arend RC, Straughn JM Jr., Toboni MD, Huh WK, Leath CA, Smith HJ, Boitano TKL, Marcom S. The use of transrectal ultrasound to improve gynecologic interstitial applicator implantation. Gynecol Oncol 200: 88-95, 2025
- Gaillard S, Alvarez J, Zhang T, Wang H, Tsai H-L, Cope L, Deery A, Palande V, Lee C-F, Fader AN, Huh WK, Arend RC, Liang MI, Straughn JM Jr., Vang R, Ostrander D, Horner K, Zhang L, Singh D, Smith KN, Wu TC, Leath CA III, Roden RBS. A randomized pilot study of PHV16 L2E7E6 fusion protein vaccination site post-treatment for HPV16+ cervical cancer. Gynecol Oncol 201: 86-96, 2025
- Neibart SS, Lin LL, Einstein MH, Teoh D, Leath CA III, Chino J. Minimum standards for radiation therapy in the treatment of cervical cancer in the U.S.: A consensus statement by SGO, ASTRO, and ABS addressing the WHO Cervical Cancer Elimination Campaign goals. Gynecol Oncol 200: 180-5, 2025
- Neibart S, Zhou N, Chino J, Earles T, Teoh D, Pinder LF, Pierce JY, Olawaiye A, Leath CA III, Einstein MH. Health equity, disparities, and barriers to cervical cancer care in the U.S.: A consensus statement by SGO, ACOG, ASCCP, ASTRO and ABS addressing the WHO cervical cancer elimination campaign goals related to treatment. Gynecol Oncol 200:186-92, 2025
- Zhou N, Beavis AL, Lin LL, Neibart SS, Chino J, Pierce JY, O’Cearbhail RE, Dewdney SB, Farid H, Chen LM, Downs LS Jr., Olawaiye AB, Boitano TKL, Einstein MH, Teoh D, Leath CA III. Embracing and implementing the WHO cervical cancer elimination campaign goals: A consensus statement by SGO, ACOG, ASCCP, ASTRO and ABS on minimum quality care standards for cervical cancer patients in the U.S. Gynecol Oncol 200: 193-202, 2025
- Ryu SY, Deng W, Albuquerque K, Koh WJ, Mayadev J, Heugel A, Kim BJ, Kim DY, Cho CH, Kim JW, No JH, Mannel RS, Miller K, Fabian D, Chase DM, Gil KM, Small W Jr., Rodgers W, Leath CA III†, Monk BJ†(† - Co-senior authors). Randomized phase III trial of adjuvant radiation versus chemoradiation in intermediate-risk, early-stage cervical cancer following radical hysterectomy and lymphadenectomy: Results from NRG Oncology/GOG-263/KGOG1008. Ann Onc 36(12): 1514-24, 2025
- Chase DM, Huang HQ, Deng W, KohWJ, Rodgers W, Small W Jr., Albuquerque K, Mayadev J, Leath CA, Monk B, Kim BJ, Kim DY, Cho CH, Kim JW, No JH, Holman L, Stuckey A, Fabian D, Smick AH, Wenzel L, Gil K, Ryu SY. Patientreported outcomes of a randomized phase III clinical trial of adjuvant radiation versus chemoradiation in intermediate risk, stage I/IIA cervical cancer patients treated with initial radical hysterectomy and pelvic lymphadenectomy (NRG/GOG- 0263). Gynecol Oncol 202: 102-9, 2025
- Kim H, Deng W, Zamarin D, Xiao Y, Chino J, Benedict S, Nguyen H, Lowenstein J, McNulty S, Ghamande S, Ferguson C, Mell L, Holman LL, Mathews C, Quick A, Olawaiye A, Hopp E, Mannel R, Leath CA III, O’Cearbhaill R, Aghajanian C, Schilder RJ, Mayadev J. Image guided brachytherapy quality assurance on NRG GY017 investigating immunotherapy in addition to chemoradiation for locally advanced cervical cancer. In press Brachytherapy
- Toboni MD, Evans ET, Scalise CB, Hardesty M, Berman T, Dinkins K, Oladipo F, Hook N, Ferguson J, Dutta P, Moore J, Oliver B, Liu MC, ElNaggar AC, Leath CA III, Arend RC. Circulating tumor DNA monitoring in ovarian cancer patients receiving PARPi maintenance therapy: Can we further personalize treatment? Gynecol Oncol 204: 37-43, 2026